Immunotherapy with T-cell-reactive peptides derived from allergens.
Wallner
B P
BP
Gefter
M L
ML
D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D000595:Amino Acid Sequence; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002415:Cats; D016207:Cytokines / Q000276:immunology; D003888:Desensitization, Immunologic; D000939:Epitopes / Q000276:immunology; D006023:Glycoproteins / Q000276:immunology / Q000627:therapeutic use; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007108:Immune Tolerance; D007073:Immunoglobulin E / Q000276:immunology; D008285:Major Histocompatibility Complex; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000485:Allergens; D016207:Cytokines; D000939:Epitopes; D006023:Glycoproteins; D000949:Histocompatibility Antigens Class II; D010455:Peptides; D007073:Immunoglobulin E; C059296:Fel d 1 protein, Felis domesticus